Zobrazeno 1 - 10
of 294
pro vyhledávání: '"Høiby Ea"'
Autor:
Johan Holst, J E Fuglesang, Einar Rosenqvist, Høiby Ea, Ingeborg S. Aaberge, Berit Feiring, Hanne Nøkleby
Publikováno v:
Vaccine. 21:734-737
For evaluation of serum bactericidal activity (SBA) as surrogate for the efficacy of outer membrane vesicle (OMV) vaccines against Neisseria meningitidis serogroup B disease, we have reanalyzed data from a randomized double blind placebo-controlled e
Publikováno v:
Journal of Immunological Methods. 196:41-49
An ELISA method was developed to quantitate gravimetrically (microgram/ml) the IgG subclass response against a Norwegian vaccine composed of outer membrane vesicles (OMV) isolated from a Neisseria meningitidis B:15:P1.7,16 epidemic strain. Chimeric m
Autor:
Odd Helge Gilja, Bjarne Bjorvatn, Haima Mylvaganam, Asbjørn Digranes, Høiby Ea, Alfred Halstensen
Publikováno v:
APMIS. 103:147-153
Following an outbreak involving 3 cases of serogroup B meningococcal disease in a rural part of Western Norway, 2 clinical and 99 carrier isolates of Neisseria meningitidis were examined by small-fragment restriction endonuclease analysis (SF-REA) us
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 21:465-467
In order to describe the clinical and microbiological manifestations of systemic pneumococcal infection in an unselected urban population, 147 cases that occurred in the period 1993-1997 were retrospectively reviewed. An unexpected finding was that g
Publikováno v:
Journal of Infectious Diseases. 167:1314-1319
The opsonic activity of sera from healthy volunteers immunized with an outer membrane vesicle vaccine prepared from a Neisseria meningitidis (class 3, 44/76, B:15:P1.7,16), characteristic of the present Norwegian epidemic, has been examined. A marked
Publikováno v:
European Journal of Clinical Microbiology & Infectious Diseases. 11:416-426
All 87 known cases of bacteraemia due toStreptococcus pyogenes (beta-haemolytic group A streptococci) occurring during the peak of a nationwide outbreak in Norway (population 4.2 million) between January and June 1988 were reviewed. Clinical features
Publikováno v:
Scandinavian journal of infectious diseases. 32(4)
We describe a case of culture-proven Brucella spondylitis in a 28-y-old Turkish male asylum seeker who had arrived to Norway 6 months earlier. Several diagnostic difficulties, including rapid in vitro growth and misidentification of the causative mic
Autor:
Brian D. Plikaytis, Hanne Nøkleby, J. Holst, D. Williams, K. Jonsdottir, Høiby Ea, Jay D. Wenger, Einar Rosenqvist, E. Tikhomirov, C V Broome, G. Sierra, George M. Carlone, F. Sotolongo, E. Griffiths, Janet K. Dykes, Bradley A. Perkins, H. Briem, D. Kapczynski, H. C. Campa
Publikováno v:
The Journal of infectious diseases. 177(3)
Serum bactericidal activity (SBA) and ELISA antibody levels elicited by two efficacious serogroup B meningococcal vaccines were measured in a controlled trial involving 408 15- to 20-year-olds. Subjects were given two doses at a 6-week interval of a
Autor:
J Eng, Ø Arnesen, J.H Fredriksen, L.K Solberg, Hanne Nøkleby, E Holten, L O Frøholm, Høiby Ea, E. Rosenqvist, Alfred Halstensen, L.S Bakketeig, O Closs, A-K Lindbak, Lystad A, B Hareide, Gunnar Bjune, Grønnesby Jk
Publikováno v:
Lancet (London, England). 338(8775)
For more than 15 years, Norway has had the highest incidence of meningococcal disease in northern Europe, with 80% of cases being due to serogroup B meningococci. The case-fatality has remained high, at about 10%. In this study, an outer membrane vac
Publikováno v:
Reviews of infectious diseases. 12(2)